Publications by authors named "Harvey I Pass"

Article Synopsis
  • Lower airway dysbiosis, characterized by an increase in specific bacteria, is linked to various severity grades of primary graft dysfunction (PGD) after lung transplantation, particularly in moderate and severe cases.
  • A study involving lower airway samples from 96 lung transplant recipients showed correlations between PGD severity and elevated levels of inflammatory markers, particularly neutrophils and specific cytokines, indicating a distinct inflammatory response.
  • Results suggest that microbial differences may influence host immune signaling, potentially exacerbating inflammation and contributing to PGD pathogenesis, highlighting the importance of microbial balance in lung health post-transplant.
View Article and Find Full Text PDF
Article Synopsis
  • This study explores the significant risk of recurrence in early-stage lung adenocarcinoma after surgical removal, noting that current methods lack biomarkers for prediction.
  • Researchers analyzed 91 patients' tumor and nearby unaffected lung tissue using specialized gene sequencing techniques to identify potential microbial and host genomic factors associated with recurrence.
  • Results revealed specific bacterial enrichments linked to recurrence in both tumor (e.g., Dialister) and unaffected lung samples (e.g., Sphingomonas), with a combined model showing strong predictive performance for recurrence using unaffected lung samples (AUC = 0.83).
View Article and Find Full Text PDF

We report that ~1.8% of all mesothelioma patients and 4.9% of those younger than 55, carry rare germline variants of the BRCA1 associated RING domain 1 ( gene that were predicted to be damaging by computational analyses.

View Article and Find Full Text PDF

Studying lung adenocarcinoma (LUAD) early carcinogenesis is challenging, primarily due to the lack of LUAD precursors specimens. We amassed multi-omics data from 213 LUAD and LUAD precursors to identify molecular features underlying LUAD precancer evolution. We observed progressively increasing mutations, chromosomal aberrations, whole genome doubling and genomic instability from precancer to invasive LUAD, indicating aggravating chromosomal instability (CIN).

View Article and Find Full Text PDF
Article Synopsis
  • The International Association for the Study of Lung Cancer created an international database to assess the need for updates to the TNM classification of diffuse pleural mesothelioma (PM) based on clinical and pathologic N categories from 2013 to 2022.
  • After analyzing 3,598 cases, the study found that the existing eighth edition N categories performed adequately, with patients classified as N0 showing better overall survival compared to N1 patients.
  • The results indicate no necessary changes to the N categories for the ninth edition of the PM staging system, as the findings support continuing the current classification.
View Article and Find Full Text PDF

Introduction: The eighth edition of the TNM classification of pleural mesothelioma (PM) saw substantial changes in T and N components and stage groupings. The International Association for the Study of Lung Cancer collected data into a multinational database to further refine this classification. This ninth edition proposal incorporates changes proposed in the clinical (c)T component but not the pathologic T component, to include size criteria, and further refines TNM stage groupings for PM.

View Article and Find Full Text PDF

Introduction: The primary tumor (T) component in the eighth edition of pleural mesothelioma (PM) staging system is based on pleural involvement and extent of invasion. Quantitative assessment of pleural tumor has been found to be prognostic. We explored quantitative and qualitative metrics to develop recommendations for T descriptors in the upcoming ninth edition of the PM staging system.

View Article and Find Full Text PDF

Acute cellular rejection (ACR) after lung transplant is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut that influence local adaptive and innate immune responses. However, the lung microbiome's overall impact on ACR risk remains poorly understood.

View Article and Find Full Text PDF

The International Association for the Study of Lung Cancer collaborated with the International Mesothelioma Interest Group to propose the first TNM stage classification system for diffuse pleural mesothelioma in 1995, accepted by the Union for International Cancer Control and the American Joint Committee on Cancer for the sixth and seventh edition stage classification manuals. The International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Mesothelioma Domain developed and analyzed an international registry of patients with pleural mesothelioma and updated TNM descriptors for the eighth edition of the stage classification system. To inform revisions for the forthcoming ninth edition of the TNM stage classification system, data submission was solicited for patients diagnosed between 2013 and 2022 with expanded data elements on the basis of the first project's exploratory analyses, including pleural thickness measurements, updated surgical nomenclature, and molecular markers.

View Article and Find Full Text PDF

Approximately 30% of early-stage lung adenocarcinoma patients present with disease progression after successful surgical resection. Despite efforts of mapping the genetic landscape, there has been limited success in discovering predictive biomarkers of disease outcomes. Here we performed a systematic multi-omic assessment of 143 tumors and matched tumor-adjacent, histologically-normal lung tissue with long-term patient follow-up.

View Article and Find Full Text PDF

Objective: Early-stage lung adenocarcinoma is treated with local therapy alone, although patients with grade 3 stage I lung adenocarcinoma have a 50% 5-year recurrence rate. Our objective is to determine if analysis of the tumor microenvironment can create a predictive model for recurrence.

Methods: Thirty-four patients with grade 3 stage I lung adenocarcinoma underwent surgical resection.

View Article and Find Full Text PDF

Lung cancer treatment has benefited greatly through advancements in immunotherapies. However, immunotherapy often fails in patients with specific mutations like KEAP1, which are frequently found in lung adenocarcinoma. We established an antigenic lung cancer model and used it to explore how Keap1 mutations remodel the tumor immune microenvironment.

View Article and Find Full Text PDF

Asbestos is the main cause of malignant mesothelioma. Previous studies have linked asbestos-induced mesothelioma to the release of HMGB1 from the nucleus to the cytoplasm, and from the cytoplasm to the extracellular space. In the cytoplasm, HMGB1 induces autophagy impairing asbestos-induced cell death.

View Article and Find Full Text PDF
Article Synopsis
  • * Lung adenocarcinoma (ADC) is the most common type of lung cancer, with atypical adenomatous hyperplasia being a key precursor that can progress to more serious forms.
  • * By using advanced deep learning techniques on common histopathology images, researchers extracted important features that show changes in cell types as lung cancer develops, suggesting that pathomics could be a cost-effective method to study lung cancer evolution.
View Article and Find Full Text PDF

Background: Cross-species immunological incompatibilities have hampered pig-to-human xenotransplantation, but porcine genome engineering recently enabled the first successful experiments. However, little is known about the immune response after the transplantation of pig kidneys to human recipients. We aimed to precisely characterise the early immune responses to the xenotransplantation using a multimodal deep phenotyping approach.

View Article and Find Full Text PDF

Introduction: The International Association for the Study of Lung Cancer developed an international pleural mesothelioma database to improve staging. Data entered from 1995 to 2009 (training data set) were analyzed previously to evaluate supplemental prognostic factors. We evaluated these factors with new clinical data to determine whether the previous models could be improved.

View Article and Find Full Text PDF

Tumor mutations can influence the surrounding microenvironment leading to suppression of anti-tumor immune responses and thereby contributing to tumor progression and failure of cancer therapies. Here we use genetically engineered lung cancer mouse models and patient samples to dissect how mutations accelerate tumor growth by reshaping the immune microenvironment. Comprehensive immune profiling of -mutant vs wildtype tumors revealed dramatic changes in myeloid cells, specifically enrichment of Arg1 interstitial macrophages and SiglecF neutrophils.

View Article and Find Full Text PDF

Background: Evidence suggests that patients critically ill with COVID-19 have a dysregulated host immune response that contributes to end-organ damage. Extracorporeal membrane oxygenation (ECMO) has been used in this population with varying degrees of success. This study was performed to evaluate the impact of ECMO on the host immunotranscriptomic response in these patients.

View Article and Find Full Text PDF

Malignant pleural effusions (MPE) complicate malignancies and portend worse outcomes. MPE is comprised of various components, including immune cells, cancer cells, and cell-free DNA/RNA. There have been investigations into using these components to diagnose and prognosticate MPE.

View Article and Find Full Text PDF

is a powerful tumor suppressor gene characterized by haplo insufficiency. Individuals carrying germline mutations often develop mesothelioma, an aggressive malignancy of the serosal layers covering the lungs, pericardium, and abdominal cavity. Intriguingly, mesotheliomas developing in carriers of germline mutations are less aggressive, and these patients have significantly improved survival.

View Article and Find Full Text PDF

Objective: Multimodality treatment for resectable non-small cell lung cancer has long remained at a therapeutic plateau. Immune checkpoint inhibitors are highly effective in advanced non-small cell lung cancer and promising preoperatively in small clinical trials for resectable non-small cell lung cancer. This large multicenter trial tested the safety and efficacy of neoadjuvant atezolizumab and surgery.

View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 is still a major public health issue, and this study focuses on the rare cardiovascular problems it can cause, specifically large- and medium-sized-vessel pathology as seen through CT scans.
  • Researchers reviewed CT reports from March to October 2020, identifying 139 patients with a confirmed COVID-19 diagnosis, among which 8 showed significant vessel issues related to the virus, with many having preexisting health conditions.
  • The findings suggest that complications can arise after COVID-19 recovery, highlighting the need for ongoing monitoring and imaging for patients who had the infection.
View Article and Find Full Text PDF

Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis and limited therapeutic options. The extracellular matrix protein fibulin-3/EFEMP1 accumulates in the pleural effusions of MPM patients and has been proposed as a prognostic biomarker of these tumors. However, it is entirely unknown whether fibulin-3 plays a functional role on MPM growth and progression.

View Article and Find Full Text PDF